Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer Patients
Clinical trial NCT01189903 · UNKNOWN
Trial details
- NCT number
- NCT01189903
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.